Overexpression of cytochrome P450 CYP2J2 protects against hypoxia-reoxygenation injury in cultured bovine aortic endothelial cells

Molecular Pharmacology

Volumn 60, Issue 2, 2001, Pages 310-320

  Yang, Baichun ^a   Graham, Lerae ^a   Dikalov, Serguei ^a   Mason, Ronald P ^a   Falck, John R ^b   Liao, James K ^c   Zeldin, Darryl C ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11,12 DIHYDROXYEICOSATRIENOIC ACID; 11,12 EPOXY 5,8,14 ICOSATRIENOIC ACID; 14,15 EPOXY 5,8,11 ICOSATRIENOIC ACID; 8 ISOPROSTAGLANDIN F2 ALPHA; ANGIOTENSIN 1 RECEPTOR; ARACHIDONIC ACID; ARGININE; COMPLEMENTARY DNA; CYTOCHROME P450 2J2; CYTOCHROME P450 ISOENZYME; DICYCLOHEXYLUREA; ENZYME INHIBITOR; EPOXIDE HYDROLASE INHIBITOR; EPOXYICOSATRIENOIC ACID; GREEN FLUORESCENT PROTEIN; LACTATE DEHYDROGENASE; NITRIC OXIDE SYNTHASE; NITRITE; SUPEROXIDE; TRYPAN BLUE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; AORTA; ARACHIDONIC ACID METABOLISM; ARTICLE; CATTLE; CELL DAMAGE; CELL PROTECTION; CONTROLLED STUDY; EPOXIDATION; HYPOXIA; LIPID PEROXIDATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REOXYGENATION; VASCULAR ENDOTHELIUM;

EID: 0034923447     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.60.2.310     Document Type: Article

References (70)

1. Beneficial actions of nitrates in cardiovascular disease
2. Hypoxia-reoxygenation stimulates endothelial cells to promote interleukin-1 and interleukin-6 production
3. Nitric oxide and superoxide production during endothelial cell proliferation
4. Reduction of urinary 8-epi-prostaglandin F2α during cyclooxygenase inhibition in rats but not in man
5. Detection of superoxide anion released extracellularly by endothelial cells using cytochrome c reduction, ESR, fluorescence and lucigenin-enhanced chemiluminescence techniques
6. Endothelial function and atherosclerosis
7. Direct cytotoxicity of hypoxia-reoxygenation towards sinusoidal endothelial cells in the rat
8. Endothelium-derived hyperpolarizing factors and vascular cytochrome P450 metabolites of arachidonic acid in the regulation of tone
9. Liver microsomal cytochrome P-450 and the oxidative metabolism of arachidonic acid
10. Cytochrome P-450 arachidonate epoxygenase
11. Inhibition of cardiac L-type calcium channels by epoxyeicosatrienoic acids
12. Controlled chemical synthesis of enzymatically produced eicosanoids 11-, 12-, and 15-HETE from arachidonic acid and conversion to corresponding HPETES
13. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines
14. Endothelium and growth factors in vascular remodeling for hypertension
15. 8,9-Epoxy arachidonic acid: A cytochrome P450 metabolite
16. Pathways of epoxyeicosatrienoic acid metabolism in endothelial cells: Implications for the vascular effects of soluble epoxide hydrolase inhibition
17. Endothelial NOS expression and ischemia-reperfusion in isolated working rat heart from hypoxic and hyperoxic conditions
18. Cytochrome P450 2C is an EDHF synthase in coronary arteries
19. Bioassay of an endothelium-derived hyperpolarizing factor from bovine coronary arteries: Role of a cytochrome P450 metabolite
20. Decreased nitric-oxide synthase activity causes impaired endothelium-dependent relaxation in the postischemic heart
21. Oxidative damage and carcinogenesis in living organisms: Oxidative stress in oxazepam-treated mice as measured by MS-based isoprostane analysis
22. 2+ entry in human and bovine endothelial cells
23. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids
24. Immunological comparison of hepatic and extrahepatic cytochromes P-450
25. Roles of constitutive nitric oxide synthase in postischemic rat retina
26. Increased expression of ICAM-1 during reoxygenation in brain endothelial cells
27. Three regulation mechanisms of nitric oxide synthase
28. Mitochondrial import and processing of mutant human ornithine transcarbamylase precursors in culture cells
29. Arachidonic acid epoxygenase: Structural characterization and quantification of epoxyeicosatrienoates in plasma
30. α in vitro and in vivo via the cyclooxygenases
31. Leukotoxin, a linoleate epoxide: Its implication in the late death of patients with extensive burns
32. Pharmacology of the endothelium in ischemia-reperfusion and circulatory shock
33. Modulation of constitutive nitric oxide synthase, Bcl-2 and Fas expression in cultured human coronary endothelial cells exposed to anoxia-reoxygenation and angiotensin II: Role of AT1 receptor activation
34. Endothelium and acute coronary syndromes
35. Regulation of bovine endothelial constitutive nitric oxide synthase by oxygen
36. Human umbilical vein endothelial cells express P450 2C8 mRNA: Cloning of endothelial P450 epoxygenase
37. Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia
38. Lipid peroxidation as molecular mechanism of liver cell injury during reperfusion after ischemia
39. Attenuated coronary relaxation after reperfusion: Effects of superoxide dismutase and TxA2 inhibitor U63,557A
40. Free radicals, antioxidants, and coronary heart disease
41. Lower ischemic heart disease incidence and mortality among vitamin supplement users
42. The first Robert Furchgott lecture: From endothelium-dependent relaxation to the L-arginine:NO pathway
43. Analysis of the cytotoxic properties of linoleic acid metabolites produced by renal and hepatic P450s
44. Potent urea and carbamate inhibitors of soluble epoxide hydrolases
45. Metabolism of arachidonate through NADPH-dependent oxygenase of renal cortex
46. Formation of novel non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in carbon tetrachloride hepatotoxicity: An animal model of lipid peroxidation
47. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism
48. Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress
49. Myocardial and endothelial protection by TMS in ischemia-reperfusion injury
50. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids
51. Activation of Gαs mediates induction of tissue-type plasminogen activator gene transcription by epodxyeicosatrienoic acids
52. Arachidonic acid metabolism in rabbit renal cortex. Formation of two novel dihydroxyeicosatrienoic acids
53. Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation
54. 2-isoprostane formation
55. 2α in acute coronary angioplasty: Evidence for oxidant stress during coronary reperfusion in humans
56. The central role of sinusoidal endothelial cells in hepatic hypoxia-reoxygenation injury in the rat
57. 2α in humans
58. Novel beneficial effects of defibrotide, an endothelium protecting agent, following ischemia and reperfusion in the isolated perfused rat heart
59. Hepatic and extrahepatic microsomal electron transport components and mixed-function oxygenases in the marine fish Stenotomus versicolor
60. Cytochrome P4501A1 induction and localization in endothelium of vertebrate (teleost) heart
61. Cellular and molecular mechanisms of inflammation and thrombosis
62. 14,15-Epoxyeicosatrienoic acid metabolism in endothelial cells
63. 2α exretion in man
64. Molecular cloning, expression, and functional significance of a cytochrome P450 highly expressed in rat heart myocytes
65. Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart
66. Critical role of AT1 receptor expression after ischemia/reperfusion in isolated rat hearts: Beneficial effect of antisense oligodeoxynucleotides directed at AT1 receptor mRNA
67. Hypoxia-reoxygenation-induced apoptosis in cultured adult rat myocytes: Protective effect of recombinant TGF-beta 1
68. Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids
69. CYP2J subfamily P450s in the gastrointestinal tract: Expression, localization, and potential functional significance
70. CYP2J subfamily cytochrome P450s in the lung: Expression, localization, and potential functional significance